155 related articles for article (PubMed ID: 30545908)
1. Regulating behavior with the flip of a translational switch.
Ceh-Pavia E; Partch CL
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13151-13153. PubMed ID: 30545908
[No Abstract] [Full Text] [Related]
2. Regulation of cell death by c-FLIP phosphorylation.
Asaoka T; Kaunisto A; Eriksson JE
Adv Exp Med Biol; 2011; 691():625-30. PubMed ID: 21153369
[No Abstract] [Full Text] [Related]
3. Targeting c-FLIP in cancer.
Shirley S; Micheau O
Cancer Lett; 2013 May; 332(2):141-50. PubMed ID: 21071136
[TBL] [Abstract][Full Text] [Related]
4. Novel phosphorylation and ubiquitination sites regulate reactive oxygen species-dependent degradation of anti-apoptotic c-FLIP protein.
Wilkie-Grantham RP; Matsuzawa S; Reed JC
J Biol Chem; 2013 May; 288(18):12777-90. PubMed ID: 23519470
[TBL] [Abstract][Full Text] [Related]
5. Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis.
Kerr E; Holohan C; McLaughlin KM; Majkut J; Dolan S; Redmond K; Riley J; McLaughlin K; Stasik I; Crudden M; Van Schaeybroeck S; Fenning C; O'Connor R; Kiely P; Sgobba M; Haigh D; Johnston PG; Longley DB
Cell Death Differ; 2012 Aug; 19(8):1317-27. PubMed ID: 22322857
[TBL] [Abstract][Full Text] [Related]
6. Activation-induced degradation of FLIP(L) is mediated via the phosphatidylinositol 3-kinase/Akt signaling pathway in macrophages.
Shi B; Tran T; Sobkoviak R; Pope RM
J Biol Chem; 2009 May; 284(21):14513-23. PubMed ID: 19339247
[TBL] [Abstract][Full Text] [Related]
7. The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis.
Raja SM; Chen S; Yue P; Acker TM; Lefkove B; Arbiser JL; Khuri FR; Sun SY
Mol Cancer Ther; 2008 Jul; 7(7):2212-23. PubMed ID: 18645030
[TBL] [Abstract][Full Text] [Related]
8. C5b-9 terminal complex protects oligodendrocytes from apoptotic cell death by inhibiting caspase-8 processing and up-regulating FLIP.
Cudrici C; Niculescu F; Jensen T; Zafranskaia E; Fosbrink M; Rus V; Shin ML; Rus H
J Immunol; 2006 Mar; 176(5):3173-80. PubMed ID: 16493077
[TBL] [Abstract][Full Text] [Related]
9. Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP.
Piggott L; Silva A; Robinson T; Santiago-Gómez A; Simões BM; Becker M; Fichtner I; Andera L; Young P; Morris C; Barrett-Lee P; Alchami F; Piva M; Vivanco MD; Clarke RB; Gee J; Clarkson R
Clin Cancer Res; 2018 May; 24(10):2452-2463. PubMed ID: 29363524
[No Abstract] [Full Text] [Related]
10. Evidence of complex formation between FADD and c-FLIP death effector domains for the death inducing signaling complex.
Hwang EY; Jeong MS; Park SY; Jang SB
BMB Rep; 2014 Sep; 47(9):488-93. PubMed ID: 24355299
[TBL] [Abstract][Full Text] [Related]
11. Mathematical modeling identified c-FLIP as an apoptotic switch in death receptor induced apoptosis.
Han L; Zhao Y; Jia X
Apoptosis; 2008 Oct; 13(10):1198-204. PubMed ID: 18726189
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells.
Abedini MR; Muller EJ; Brun J; Bergeron R; Gray DA; Tsang BK
Cancer Res; 2008 Jun; 68(12):4511-7. PubMed ID: 18559494
[TBL] [Abstract][Full Text] [Related]
13. S-nitrosylation of FLICE inhibitory protein determines its interaction with RIP1 and activation of NF-κB.
Talbott SJ; Luanpitpong S; Stehlik C; Azad N; Iyer AK; Wang L; Rojanasakul Y
Cell Cycle; 2014; 13(12):1948-57. PubMed ID: 24762656
[TBL] [Abstract][Full Text] [Related]
14. Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.
Jin TG; Kurakin A; Benhaga N; Abe K; Mohseni M; Sandra F; Song K; Kay BK; Khosravi-Far R
J Biol Chem; 2004 Dec; 279(53):55594-601. PubMed ID: 15485835
[TBL] [Abstract][Full Text] [Related]
15. Regulation of extrinsic apoptotic signaling by c-FLIP: towards targeting cancer networks.
Ivanisenko NV; Seyrek K; Hillert-Richter LK; König C; Espe J; Bose K; Lavrik IN
Trends Cancer; 2022 Mar; 8(3):190-209. PubMed ID: 34973957
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonists.
McCann C; Crawford N; Majkut J; Holohan C; Armstrong CWD; Maxwell PJ; Ong CW; LaBonte MJ; McDade SS; Waugh DJ; Longley DB
Cell Death Dis; 2018 Oct; 9(11):1081. PubMed ID: 30349042
[TBL] [Abstract][Full Text] [Related]
17. FLIP(L): the pseudo-caspase.
Smyth P; Sessler T; Scott CJ; Longley DB
FEBS J; 2020 Oct; 287(19):4246-4260. PubMed ID: 32096279
[TBL] [Abstract][Full Text] [Related]
18. FLIP(L) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity.
Pop C; Oberst A; Drag M; Van Raam BJ; Riedl SJ; Green DR; Salvesen GS
Biochem J; 2011 Feb; 433(3):447-457. PubMed ID: 21235526
[TBL] [Abstract][Full Text] [Related]
19. [Expression of c-FLIP in peripheral blood mononuclear cells of patients with rheumatoid arthritis and its relation with extrinsic apoptotic pathway].
Lin M; Xu R; Zhang T; Zhang L; Mei X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 47(4):381-388. PubMed ID: 30511525
[TBL] [Abstract][Full Text] [Related]
20. The SCF
Roberts JZ; Holohan C; Sessler T; Fox J; Crawford N; Riley JS; Khawaja H; Majkut J; Evergren E; Humphreys LM; Ferris J; Higgins C; Espona-Fiedler M; Moynagh P; McDade SS; Longley DB
Cell Death Differ; 2020 Sep; 27(9):2726-2741. PubMed ID: 32313199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
